טוען...
Role of ethambutol and rifampicin in the treatment of Mycobacterium avium complex pulmonary disease
BACKGROUND: A three-drug regimen (macrolide, ethambutol, and rifampicin) is recommended for the treatment of Mycobacterium avium complex pulmonary disease (MAC-PD). Although macrolide has proven efficacy, the role of ethambutol and rifampicin in patients without acquired immune deficiency syndrome i...
שמור ב:
| הוצא לאור ב: | BMC Pulm Med |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6849249/ https://ncbi.nlm.nih.gov/pubmed/31711459 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12890-019-0982-8 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|